Mictura-DS Tablet

Quick info

Mictura-DS Tablet is a combination medicine used to treat symptoms of an enlarged prostate gland in men, such as difficulty urinating or frequent urination. Mictura-DS Tablet is a combination of two medicines, Silodosin and Dutasteride, that work together to relieve symptoms of benign prostatic hyperplasia (BPH). Silodosin is an alpha-blocker that relaxes the muscles around the bladder exit and prostate gland, facilitating easier urine passage. Dutasteride is a 5-alpha-reductase inhibitor that helps shrink the prostate gland by reducing hormone levels that contribute to its growth. This medication is not intended to prevent prostate cancer. Common side effects may include dizziness, blurred vision, and sexual dysfunction. Always consult your doctor for personalized advice and information.

How it works

Mictura-DS Tablet combines Silodosin and Dutasteride to relieve BPH symptoms. Silodosin relaxes the muscles around the bladder exit and prostate gland, allowing easier urine passage. Dutasteride reduces hormone levels that help the prostate gland grow, thereby shrinking it.

Direction of use

Take this medicine in the dose and duration as advised by your doctor. Swallow it whole without chewing, crushing, or breaking it. Mictura-DS Tablet should be taken with food, approximately 30 minutes after the same meal each day.

Tips

• You have been prescribed Mictura-DS Tablet to relieve the symptoms of benign prostatic hyperplasia (BPH).
• Take it approximately 30 minutes after the same meal each day.
• Mictura-DS Tablet may cause dizziness or blurring of vision. Do not drive or do anything requiring concentration until you know how it affects you.
• To lower the chance of feeling dizzy or passing out, rise slowly if you have been sitting or lying down.
• If you are scheduled to undergo eye surgery due to cataract or glaucoma, inform your eye doctor about the usage of Mictura-DS Tablet.
• It may cause difficulty achieving or maintaining an erection (impotence), decreased sex drive, and ejaculation disorders such as decreased amount of semen produced or decreased sperm count.
• Do not donate blood for 6 months after taking the last dose of Mictura-DS Tablet.